Ex-vivo expansion of NK cells: what is the priority--high yield or high purity?

Cytotherapy. 2010 Dec;12(8):969-70. doi: 10.3109/14653249.2010.536216.
No abstract available

Publication types

  • Introductory Journal Article
  • Comment

MeSH terms

  • Antigens, Differentiation
  • Bioreactors
  • CD56 Antigen / biosynthesis
  • Cell Culture Techniques
  • Cell Proliferation
  • Cytotoxicity, Immunologic
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / prevention & control
  • Humans
  • Immunotherapy, Adoptive / adverse effects*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism*
  • Killer Cells, Natural / pathology
  • Killer Cells, Natural / transplantation
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / metabolism*
  • Lymphocyte Subsets / pathology
  • Lymphocyte Subsets / transplantation
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / pathology
  • T-Lymphocytes / transplantation

Substances

  • Antigens, Differentiation
  • CD56 Antigen